… Washburn received his Ph.D. in Organic Chemistry in 1971 from Columbia University,
studying non-… Washburn’s focus has been programs pertaining to obesity and type 2 diabetes. …

The C-aryl glucoside 6 (dapagliflozin) was identified as a potent and selective hSGLT2 inhibitor
which reduced blood glucose levels in a dose-dependent manner by as much as 55% in …

Background: A critical factor for maintenance of glucose balance is the renal recovery of
glucose from the glomerular filtrate mediated primarily by sodium glucose co-transporter 2 (…

… W Washburn is an employee and shareholder of Bristol-Myers Squibb and S Poucher was
an employee of AstraZeneca during the development of this article and is a shareholder of …

OBJECTIVE—The inhibition of gut and renal sodium-glucose cotransporters (SGLTs) has
been proposed as a novel therapeutic approach to the treatment of diabetes. We have …

Importance Ischemic cold storage (ICS) of livers for transplant is associated with serious
posttransplant complications and underuse of liver allografts. Objective To determine whether …

Steroid esters of benzophenonecarboxylic acids, benzophenoneacetic acids, and homologs
are prepared. Circular dichroism studies indicatethat in some of these compounds the …

(2S,3R,4R,5S,6R)-2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyl-tetrahydro-2H-pyran-3,4,5-triol
(dapagliflozin; BMS-512148) is a potent sodium-glucose cotransporter type II …

… curbside trash cans everywhere, Washburn and I sought balance. … Heretics that we were,
Washburn and I must have struck … I am pleased with that record, and I know Wilcomb Washburn …

Liver transplantation numbers in the United States remained constant from 2004 to 2007, while
the number of waiting list candidates has trended down. In 2007, the waiting list was at its …